Fetal dokularda saptanan“mozaisizmin”prenatal tanıda önemi
Başlık çevirisi mevcut değil.
- Tez No: 40764
- Danışmanlar: DOÇ.DR. SEHER BAŞARAN
- Tez Türü: Yüksek Lisans
- Konular: Tıbbi Biyoloji, Medical Biology
- Anahtar Kelimeler: Embriyo, Kromozom düzensizlikleri, Mozaisizm, Prenatal teşhis, Embryo, Chromosome aberrations, Mosaicism, Prenatal diagnosis
- Yıl: 1994
- Dil: Türkçe
- Üniversite: İstanbul Üniversitesi
- Enstitü: Sağlık Bilimleri Enstitüsü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
88 frequency of pseudomosaicism ranged from 0. 64% to 1.1% in the amniotic fluid cell cultures and 0.47% to 1.0% in CVS cultures although the ratio of false - negative cases is reported as 0.19%; no such cases were observed in our series. In our series, pseudomosaicism was observed in 0.44% of amniocentesis and in 1.3% of CVS series. Confined placental mosaicism is reported as being in the range of 0.47% to 1%. This finding was observed 1.3% in our CVS series. The ratio of false - negative cases is reported as 0.97% ; the frequency of this finding was 1.3% in our series. MCC and mosaicism is more common in CVS cultures than in amniotic fluid cell cultures. To reduce the risk of MCC, a careful dissection and removal of maternal decidua in a chorionic villus sample is a must. When direct preparation is not available and a 46, XX cell line is observed in a long - term CVS culture, Q banding must be performed to distinguish maternal chromosomes from the fetal ones. In CVS applications, the results obtained only by DP shouldn't be interpretated as the final result since DP has a high false - negativity risk.89 If mosaicism is observed in the CVS studies, fetal tissues ( amniotic fluid and fetal blood ) and postnatal study of the placenta should be assessed. Sufficient number of metaphases and multiple culture plates should be analyzed not to miss mosaicism.88 frequency of pseudomosaicism ranged from 0. 64% to 1.1% in the amniotic fluid cell cultures and 0.47% to 1.0% in CVS cultures although the ratio of false - negative cases is reported as 0.19%; no such cases were observed in our series. In our series, pseudomosaicism was observed in 0.44% of amniocentesis and in 1.3% of CVS series. Confined placental mosaicism is reported as being in the range of 0.47% to 1%. This finding was observed 1.3% in our CVS series. The ratio of false - negative cases is reported as 0.97% ; the frequency of this finding was 1.3% in our series. MCC and mosaicism is more common in CVS cultures than in amniotic fluid cell cultures. To reduce the risk of MCC, a careful dissection and removal of maternal decidua in a chorionic villus sample is a must. When direct preparation is not available and a 46, XX cell line is observed in a long - term CVS culture, Q banding must be performed to distinguish maternal chromosomes from the fetal ones. In CVS applications, the results obtained only by DP shouldn't be interpretated as the final result since DP has a high false - negativity risk.
Özet (Çeviri)
89 If mosaicism is observed in the CVS studies, fetal tissues ( amniotic fluid and fetal blood ) and postnatal study of the placenta should be assessed. Sufficient number of metaphases and multiple culture plates should be analyzed not to miss mosaicism.88 frequency of pseudomosaicism ranged from 0. 64% to 1.1% in the amniotic fluid cell cultures and 0.47% to 1.0% in CVS cultures although the ratio of false - negative cases is reported as 0.19%; no such cases were observed in our series. In our series, pseudomosaicism was observed in 0.44% of amniocentesis and in 1.3% of CVS series. Confined placental mosaicism is reported as being in the range of 0.47% to 1%. This finding was observed 1.3% in our CVS series. The ratio of false - negative cases is reported as 0.97% ; the frequency of this finding was 1.3% in our series. MCC and mosaicism is more common in CVS cultures than in amniotic fluid cell cultures. To reduce the risk of MCC, a careful dissection and removal of maternal decidua in a chorionic villus sample is a must. When direct preparation is not available and a 46, XX cell line is observed in a long - term CVS culture, Q banding must be performed to distinguish maternal chromosomes from the fetal ones. In CVS applications, the results obtained only by DP shouldn't be interpretated as the final result since DP has a high false - negativity risk.89 If mosaicism is observed in the CVS studies, fetal tissues ( amniotic fluid and fetal blood ) and postnatal study of the placenta should be assessed. Sufficient number of metaphases and multiple culture plates should be analyzed not to miss mosaicism.
Benzer Tezler
- Prenatal sonografide saptanan plasenta patolojilerinde obstetrik ve perinatal sonuçlar
Prenatal ultrasound diagnosis and obstetric and perinatal outcome of placental pathology
MAHMUT TUNCAY ÖZGÜN
Tıpta Uzmanlık
Türkçe
2003
Kadın Hastalıkları ve Doğumİstanbul ÜniversitesiKadın Hastalıkları ve Doğum Ana Bilim Dalı
PROF. DR. ATIL YÜKSEL
- İntrauterin gelişme geriliği saptanan gebeliklerde, plasenta ve göbek kordonunda ürotensin ıı ekspresyonunun histolojik ve biyokimyasal yöntemlerle araştırılması
Investigation of urotensin ii expression in placenta and umbilical cord in pregnancies with intrauterine growth restriction by histological and biochemical methods
RAZİYE ALACA
Tıpta Uzmanlık
Türkçe
2021
Histoloji ve EmbriyolojiAtatürk ÜniversitesiHistoloji ve Embriyoloji Ana Bilim Dalı
DOÇ. DR. TUBA DEMİRCİ
- Mezenkimal stromal hücrelerin crohn hastalığı modelinde inflamatuar ve proinflamatuar sitokinlere etkisi ve tedavide kullanımı
The effect of mesenchymal stromal cells to inflamatuar and proinflamatuar cytokines at crohn disease model and their role in therapy
İBRAHİM VOLKAN ŞENKAL
Tıpta Uzmanlık
Türkçe
2010
GastroenterolojiYeditepe Üniversitesiİç Hastalıkları Ana Bilim Dalı
PROF. DR. CENGİZ PATA
- Preeklampsili hastaların plasenta, plasenta yatağı ve kordon dokusunda gen ekspresyon analizi
Gene expression analysis in placenta, placental bed and cord tissue of patients with preeclampsia
ZEYNEP ŞİMŞEK
Yüksek Lisans
Türkçe
2022
Moleküler TıpYıldız Teknik ÜniversitesiMoleküler Biyoloji ve Genetik Ana Bilim Dalı
PROF. DR. NEHİR ÖZDEMİR ÖZGENTÜRK